Skip to main content

Table 2 Summary information per RCT assessed for MVHT using refined set of domains and judgmental criteria

From: Method for appraising model validity of randomised controlled trials of homeopathic treatment: multi-rater concordance study

Paper

Attributes of RCT

First author, year

Medical condition studied

Homeopathic intervention

Comparison group

'Main' outcome measure

Length of follow-up

Lewith, 2002 [26]

Allergic asthma

House dust mite

Placebo

Asthma VAS

16 wk

Kainz, 1996 [27]

Warts

Individualised

(from 10 options)

Placebo

Responders: patients with at least 50% reduction in area of skin affected by warts

8 wk

McCutcheon, 1996 [28]

Anxiety

Combination

(9 medicines)

Placebo

State Anxiety score

15 d

Bell, 2004 [29]

Fibromyalgia

Individualised

Placebo

Tender point pain on palpation

3 mo

Robertson, 2007 [30]

Post-operative pain

Arnica montana

Placebo

Change in tonsillectomy pain score (VAS)

14 d

Adler, 2009 [31]

Depression

Individualised

Fluoxetine

Change in MADRS score from baseline

8 wk

  1. 'Main' outcome measure was identified per RCT using the WHO International Classification of Functioning, Disability and Health, 2002 [32]
  2. MADRS Montgomery & Åsberg Depression Rating Scale
  3. VAS Visual Analogue Scale